Previous Section
Review Articles
31. Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference.
- Author
- Buchholz TA; Lehman CD; Harris JR; Pockaj BA; Khouri N; Hylton NF; Miller MJ; Whelan T; Pierce LJ; Esserman LJ; Newman LA; Smith BL; Bear HD; Mamounas EP;
- Institution
- Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcolmbe Blvd, Unit 1202, Houston, TX 77030, USA. tbuchhol@mdanderson.org
- Journal
- J Clin Oncol. 2008 Feb 10;26(5):791-7.
- Abstract URL
- Click here to view abstract
32. Locally advanced and inflammatory breast cancer.
- Author
- Chia S; Swain SM; Byrd DR; Mankoff DA;
- Institution
- Department of Medical Oncology, British Columbia Cancer Agency, 600 West 10th Ave, Vancouver, British Columbia, Canada. schia@bccancer.bc.ca
- Journal
- J Clin Oncol. 2008 Feb 10;26(5):786-90.
33. Implementing a survivorship care plan for patients with breast cancer.
- Author
- Ganz PA; Hahn EE;
- Institution
- Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, 650 Charles Young Dr South, Room A2-125 CHS, Los Angeles, CA 90095-6900, USA. pganz@ucla.edu
- Journal
- J Clin Oncol. 2008 Feb 10;26(5):759-67.
- Abstract URL
- Click here to view abstract
34. Controversies in the management of patients with breast cancer: adjuvant endocrine therapy in premenopausal women.
- Author
- Parton M; Smith IE;
- Institution
- Breast Unit, The Royal Marsden Hospital, Institute of Cancer Research, London, United Kingdom.
- Journal
- J Clin Oncol. 2008 Feb 10;26(5):745-52.
35. Breast cancer and sexuality.
- Author
- Sheppard LA; Ely S;
- Institution
- University of South Australia, Adelaide, South Australia, Australia. lorraine.sheppard@unisa.edu.au
- Journal
- Breast J. 2008 Mar-Apr;14(2):176-81. Epub 2008 Jan 31.
- Abstract URL
- Click here to view abstract
36. Trastuzumab as the lead monoclonal antibody in advanced breast cancer: choosing which patient and when.
- Author
- Olver IN;
- Institution
- The Cancer Council Australia, Level 1, 120 Chalmers Street, Surry Hills, NSW 2010, Australia. ian.olver@cancer.org.au
- Journal
- Future Oncol. 2008 Feb;4(1):125-31.
- Abstract URL
- Click here to view abstract
37. Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory.
- Author
- Nahleh Z;
- Institution
- Wayne State University, Karmanos Cancer Institute, 4100 John R, 4HWCRC, Detroit, MI 48201, USA. nahlehz@karmanos.org
- Journal
- Future Oncol. 2008 Feb;4(1):15-21.
- Abstract URL
- Click here to view abstract
38. Aromatase inhibitors in early breast-cancer treatment: The story so far.
- Author
- Cuzick J;
- Institution
- Cancer Research UK, Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Charterhouse Square, London EC1M 6BQ, UK. jack.cuzick@cancer.org.uk
- Journal
- Breast. 2008 Apr;17 Suppl 3:S2-8.
- Abstract URL
- Click here to view abstract
39. Pegylated liposomal doxorubicin in elderly patients with metastatic breast cancer.
- Author
- Minisini AM; Andreetta C; Fasola G; Puglisi F;
- Institution
- University and General Hospital of Udine, Department of Oncology, Udine, Italy. minisini.alessandro@aoud.sanita.fvg.it
- Journal
- Expert Rev Anticancer Ther. 2008 Mar;8(3):331-42.
- Abstract URL
- Click here to view abstract
40. Ixabepilone, a novel epothilone analog in the treatment of breast cancer.
- Author
- Pivot X; Villanueva C; Chaigneau L; Nguyen T; Demarchi M; Maurina T; Stein U; Borg C;
- Institution
- Oncologie Medicale, CHU J Minjoz, 25000 Besancon, France. xavier.pivot@univ-fcomte.fr
- Journal
- Expert Opin Investig Drugs. 2008 Apr;17(4):593-9.
- Abstract URL
- Click here to view abstract
